Literature DB >> 23555342

Cell therapy for cardiovascular diseases.

Kaoru Tateno1, Tohru Minamino, Junji Moriya, Akemi Katada, Masataka Yokoyama, Kentaro Miura, Issei Komuro.   

Abstract

There have been great progresses in our knowledge of patho-physiology on various cardiovascular diseases, which enabled us to develop the field of regenerative medicine for previously untreatable patients. Among several strategies in cardiovascular regenerative medicine, cell transplantation is one of the best studied and the best clinically practiced. In this review we will first summarize the mechanisms of cell therapy, and then go through lists of cells and diseases that can be applied. Later we will introduce some of the clinical experiences published so far, with some discussion regarding the problems and perspectives of this novel therapeutics.

Entities:  

Keywords:  angiogenesis; ischemic heart disease; neovascularization; peripheral artery disease

Year:  2008        PMID： 23555342      PMCID： PMC3595728          DOI： 10.3400/avd.AVDsr00108

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN： 1881-641X


  81 in total

1.  Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study.

Authors:  Sandra Erbs; Axel Linke; Volker Adams; Karsten Lenk; Holger Thiele; Klaus-Werner Diederich; Frank Emmrich; Regine Kluge; Kai Kendziorra; Osama Sabri; Gerhard Schuler; Rainer Hambrecht
Journal:  Circ Res       Date:  2005-09-08       Impact factor: 17.367

2.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

3.  Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.

Authors:  M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii
Journal:  Blood       Date:  2000-02-01       Impact factor: 22.113

4.  Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up.

Authors:  Nabil Dib; Robert E Michler; Francis D Pagani; Susan Wright; Dean J Kereiakes; Rose Lengerich; Philip Binkley; Diane Buchele; Inder Anand; Cory Swingen; Marcelo F Di Carli; James D Thomas; Wael A Jaber; Shaun R Opie; Ann Campbell; Patrick McCarthy; Michael Yeager; Vasken Dilsizian; Bartley P Griffith; Ronald Korn; Steven K Kreuger; Marwan Ghazoul; W Robb MacLellan; Gregg Fonarow; Howard J Eisen; Jonathan Dinsmore; Edward Diethrich
Journal:  Circulation       Date:  2005-09-20       Impact factor: 29.690

5.  Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.

Authors:  Dietlind Zohlnhöfer; Ilka Ott; Julinda Mehilli; Kathrin Schömig; Fabian Michalk; Tareq Ibrahim; Günther Meisetschläger; Jasper von Wedel; Hildegard Bollwein; Melchior Seyfarth; Josef Dirschinger; Claus Schmitt; Markus Schwaiger; Adnan Kastrati; Albert Schömig
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

6.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

7.  Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model.

Authors:  T Kobayashi; K Hamano; T S Li; T Katoh; S Kobayashi; M Matsuzaki; K Esato
Journal:  J Surg Res       Date:  2000-04       Impact factor: 2.192

8.  Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.

Authors:  Pingping Huang; Shangzhu Li; Mingzhe Han; Zhijian Xiao; Renchi Yang; Zhong Chao Han
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

Review 9.  Skeletal muscle satellite cell transplantation.

Authors:  Philippe Menasché
Journal:  Cardiovasc Res       Date:  2003-05-01       Impact factor: 10.787

10.  Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts.

Authors:  Charles E Murry; Mark H Soonpaa; Hans Reinecke; Hidehiro Nakajima; Hisako O Nakajima; Michael Rubart; Kishore B S Pasumarthi; Jitka Ismail Virag; Stephen H Bartelmez; Veronica Poppa; Gillian Bradford; Joshua D Dowell; David A Williams; Loren J Field
Journal:  Nature       Date:  2004-03-21       Impact factor: 49.962
View more
  2 in total

1.  Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.

Authors:  Naoyoshi Aoyama; Makoto Nishinari; Shinichi Ohtani; Akifumi Kanai; Chiharu Noda; Mitsuhiro Hirata; Akira Miyamoto; Masafumi Watanabe; Tohru Minamino; Tohru Izumi; Jyunya Ako
Journal:  Heart Vessels       Date:  2017-03-29       Impact factor: 2.037

Review 2.  Angiogenesis, Cancer, and Vascular Aging.

Authors:  Junji Moriya; Tohru Minamino
Journal:  Front Cardiovasc Med       Date:  2017-10-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.